About Us

Our Company

Our Leadership

Our History

Development process

2014

Founded ClinBridge Pharmacodynamic screening platform established for animal orthotopic tumor models.

2018

Registered in Nanjing Biotech Valley Animal imaging capabilities

2021

Established new platforms Moved in Nanjing BPV Expanded animal facilities and laboratories Introduction of IO platform

2022

Co-development of preclinical pharmacological research platform with Nanjing BPV Recruitment of industry leader partners ALAAAC application

2023

ALAAAC certification IO and high-end I&I platform expansion Lab expansion: Addition of Bio-analytical center Introduce ecosphere strategic partners and capital partners DMPK capability expansion Accredited as a high-tech enterprise